Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Expert synthesis of the literature to support critical care decision making.

Jerome RN, Miller RA.

J Med Libr Assoc. 2006 Oct;94(4):376-81. No abstract available.

2.

Therapeutic options for Acinetobacter baumannii infections.

Vila J, Pachón J.

Expert Opin Pharmacother. 2008 Mar;9(4):587-99. doi: 10.1517/14656566.9.4.587. Review.

PMID:
18312160
3.

Colistin and polymyxin B in critical care.

Michalopoulos A, Falagas ME.

Crit Care Clin. 2008 Apr;24(2):377-91, x. doi: 10.1016/j.ccc.2007.12.003. Review.

PMID:
18361952
4.

Acinetobacter baumannii: an emerging multidrug-resistant pathogen in critical care.

Montefour K, Frieden J, Hurst S, Helmich C, Headley D, Martin M, Boyle DA.

Crit Care Nurse. 2008 Feb;28(1):15-25; quiz 26. Review. No abstract available.

5.

Acinetobacter infection in the ICU.

Murray CK, Hospenthal DR.

Crit Care Clin. 2008 Apr;24(2):237-48, vii. doi: 10.1016/j.ccc.2007.12.005. Review.

PMID:
18361943
6.

[Computational analyses of biomedical literature for understanding living organisms].

Yamamoto Y, Takagi T.

Tanpakushitsu Kakusan Koso. 2005 Dec;50(16 Suppl):2244-9. Review. Japanese. No abstract available.

PMID:
16411457
7.

Acinetobacter baumannii: a universal threat to public health?

Giamarellou H, Antoniadou A, Kanellakopoulou K.

Int J Antimicrob Agents. 2008 Aug;32(2):106-19. doi: 10.1016/j.ijantimicag.2008.02.013. Epub 2008 Jun 20. Review.

PMID:
18571905
8.

Approaching and analyzing a large literature on vancomycin monitoring and pharmacokinetics.

Lee P, DiPersio D, Jerome RN, Wheeler AP.

J Med Libr Assoc. 2007 Oct;95(4):374-80. Review. No abstract available.

9.

The role of carbapenems in the treatment of severe nosocomial respiratory tract infections.

Joseph J, Rodvold KA.

Expert Opin Pharmacother. 2008 Mar;9(4):561-75. doi: 10.1517/14656566.9.4.561. Review.

PMID:
18312158
10.

Treatment of multiresistant Acinetobacter baumannii infections.

Pachón J, Vila J.

Curr Opin Investig Drugs. 2009 Feb;10(2):150-6. Review.

PMID:
19197792
11.

Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence.

Karageorgopoulos DE, Kelesidis T, Kelesidis I, Falagas ME.

J Antimicrob Chemother. 2008 Jul;62(1):45-55. doi: 10.1093/jac/dkn165. Epub 2008 Apr 24. Review.

12.

Acinetobacter baumannii: an emerging multidrug-resistant threat.

Gootz TD, Marra A.

Expert Rev Anti Infect Ther. 2008 Jun;6(3):309-25. doi: 10.1586/14787210.6.3.309. Review.

PMID:
18588496
13.

An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii.

Dijkshoorn L, Nemec A, Seifert H.

Nat Rev Microbiol. 2007 Dec;5(12):939-51. Review.

PMID:
18007677
14.

Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options.

Maragakis LL, Perl TM.

Clin Infect Dis. 2008 Apr 15;46(8):1254-63. doi: 10.1086/529198. Review.

16.

CPD: Searching the literature: advanced techniques for exhaustive searching.

Shelling J.

Collegian. 2003 Jul;10(3):36-8; quiz 38. Review. No abstract available.

PMID:
14582951
Items per page

Supplemental Content

Write to the Help Desk